Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Loss	Total
Beginning balance, shares at Dec. 31, 2023	33,260,011
Beginning treasury stock, shares at Dec. 31, 2023		(711,231)
Beginning balance at Dec. 31, 2023	$ 333	$ (6,540)	$ 189,729	$ (62,047)	$ 121,475
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation			358		358
Exercise of stock options			294		$ 294
Exercise of stock options, shares	46,322				46,322
Issuance of restricted stock	$ 3		(3)
Issuance of restricted stock, shares	275,954
Forfeiture of restricted stock, shares	(6,942)
Net loss				(6,057)	$ (6,057)
Ending balance, shares at Mar. 31, 2024	33,575,345
Ending treasury stock, shares at Mar. 31, 2024		(711,231)
Ending balance at Mar. 31, 2024	$ 336	$ (6,540)	190,378	(68,104)	$ 116,070
Beginning balance, shares at Dec. 31, 2024	39,681,597				39,681,597
Beginning treasury stock, shares at Dec. 31, 2024		(711,231)			(711,231)
Beginning balance at Dec. 31, 2024	$ 397	$ (6,540)	220,513	(63,691)	$ 150,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation			1,123		1,123
Exercise of stock options			108		$ 108
Exercise of stock options, shares	15,000				15,000
Issuance of restricted stock	$ 5		(5)
Issuance of restricted stock, shares	499,036
Forfeiture of restricted stock, shares	(10,960)
Employee share purchase plan issuance	$ 1		336		$ 337
Employee share purchase plan issuance, shares	71,133
Net loss				(1,414)	$ (1,414)
Ending balance, shares at Mar. 31, 2025	40,255,806				40,255,806
Ending treasury stock, shares at Mar. 31, 2025		(711,231)			(711,231)
Ending balance at Mar. 31, 2025	$ 403	$ (6,540)	$ 222,075	$ (65,105)	$ 150,833